¿­·¢k8¹ú¼Ê

ȪԴ£ºÖ¤È¯Ê±±¨Íø×÷Õߣº°¢»ùŵ2025-08-10 00:06:10
huisdkbgjwehrfoisdklfjq Ôڸ߼ÓË÷ÈËÖÖÅ®ÐÔȺÌåÖÐ £¬¸¹²¿Ö¬·¾Ò쳣Ⱥ¼¯Õ÷Ïó±¸ÊܹØ×¢¡£±¾ÎĽ«´ÓÉúÎïҽѧ½Ç¶ÈÆÊÎöÖÐÄêÅ®ÐÔ¸¹²¿Ö¬·¾Õð²üÕ÷Ï󱳺óµÄ²¡Àí»úÖÆ £¬Ì½ÌÖÖ¬·¾²ü¶¶Óë´úлʧºâµÄÄÚÔÚ¹ØÁª £¬²¢Ìṩ¿ÆÑ§ÓÐÓõĸÉÔ¤Õ½ÂÔ¡£Í¨¹ýÁ¬Ïµ»ùÒòÌØÕ÷ÓëÇéÐÎÒòËØ £¬ÎÒÃǽ«ÏµÍ³ÐÔ²ð½âÕâ¸öÀ§ÈÅÎÞÊýÅ®ÐԵĿµ½¡ÃÕÌâ¡£

¸ß¼ÓË÷Å®ÐÔ¸¹²¿·ÊÅÖ³ÉÒòÆÊÎö - Ö¬·¾²ü¶¶Óë´úл¿µ½¡È«½â¶Á


Ò»¡¢¸¹±Ú×éÖ¯µÄÉúÎïÁ¦Ñ§ÌØÖÊÆÊÎö

¸ß¼ÓË÷Å®ÐÔµÄÆ¤ÏÂÖ¬·¾£¨Subcutaneous adipose tissue£©¾ßÓÐÆæÒìµÄÂþÑÜģʽ £¬Æä¸¹²¿ÕæÆ¤²ã£¨Dermis£©Óëdz½îĤ£¨Superficial fascia£©¼äµÄ½áµÞ×éÖ¯½ÏÆäËûÈËÖÖ¸üΪËÉÉ¢¡£ÕâÖÖÆÊ½âÑ§ÌØÕ÷µ¼Ö³ÉÄêÅ®ÐÔÔÚÌåÖØÔöÌíʱ £¬¸¹²¿Ö¬·¾¸üÈÝÒ×·ºÆð"º£ÃàÑù"´¹×¹×´Ì¬¡£µ±ÎÒÃÇÊÓ²ìÖ¬·¾²ü¶¶Õ÷Ïóʱ £¬ÊµÖÊÉÏÊÇdz²ãÖ¬·¾ÔÚÖØÁ¦×÷ÓÃϱ¬·¢µÄ¶¯Ì¬Î»ÒÆ £¬¸ÃÀú³ÌÉæ¼°Ö¬·¾Ï¸°ûµÄ»úеӦÁ¦ÏìÓ¦Óë½áµÞ×éÖ¯ÍøµÄµ¯ÐÔË¥¼õ¡£


¶þ¡¢´Æ¼¤Ëز¨¶¯ÓëÖ¬·¾Èº¼¯µÄDZÔÚ¹ØÁª

ÄÚÉøÍ¸ÏµÍ³µÄÖÜÆÚÐÔת±äÉî¿ÌÓ°Ïì×ÅÖ¬·¾ÂþÑÜ¡£35Ëêºó £¬Å®ÐԴƶþ´¼£¨Estradiol£©Ë®Æ½Ã¿ÄêÒÔ2.4%µÄËÙÂʵݼõ £¬ÕâÖÖ¼¤ËØ×ª±äÖ±½Ó¸Ä±äÖ¬ÂѰ×ø£¨Lipoprotein lipase£©»îÐÔ¡£ÖµµÃ˼Ë÷µÄÊÇ £¬ÎªºÎÍ£¾­ºóµÄ¸ß¼ÓË÷Å®ÐÔ¸üÒ×±¬·¢ÄÚÔàÖ¬·¾£¨Visceral adipose tissue£©Èº¼¯£¿Ñо¿ÏÔʾ £¬´Æ¼¤ËØÊÜÌå¦Á£¨ER¦Á£©ÔÚ¸¹²¿µÄ±í´ïÃܶÈÏÔÖø¸ßÓÚÆäËû²¿Î» £¬µ±¼¤ËØË®Æ½Ê§ºâʱ £¬Ö¬·¾Ï¸°ûÔöÖ³ËÙÂʿɴïÆäËû²¿Î»µÄ3±¶¡£


Èý¡¢Ìض¨ÎÄ»¯ÏµÄÒûʳÐÐΪÆÊÎö

¶«Å·¹Å°åÒûʳÖеĸßÈéÖ¬ÉãÈëϰ¹ßÓëÏÖ´úÉúÑÄ·½·¨ÐγÉΣÏÕµþ¼ÓЧӦ¡£¿ËÀ­Ë¹Åµ´ï¶û±ß½®ÇøµÄÓªÑøÊÓ²ìÏÔʾ £¬ÍâµØ¸¾Å®ÖðÈÕ±¥ºÍÖ¬·¾ÉãÈëÁ¿³¬WHO±ê×¼87%¡£µ±´ó×Ú¶ÌÁ´Ö¬·¾ËᣨSCFAs£©½øÈëÞ²ÂöÑ­»·Ê± £¬»áÒý·¢ÒȵºËØÃô¸ÐÐÔϽµ£¨Insulin resistance£©µÄ´ú³¥ÐÔ»úÖÆ¡£ÎªºÎÕâÖÖ´úлÔÓÂÒÌåÏÖÔÚ¸¹²¿£¿ÕâÓ븹ÄÚÖ¬·¾×éÖ¯µÄ¸ß¶È´úл»îÐÔÇ×½üÏà¹Ø¡£


ËÄ¡¢°ÐÏò¼õÖ¬µÄÔ˶¯´¦·½Öƶ©

¶Ô¿¹¸¹²¿Ö¬·¾Ðè¹¹½¨Ë«ÖظÉÔ¤Õ½ÂÔ£ºÓÐÑõÔ˶¯£¨Aerobic exercise£©Í¨¹ýÓÕµ¼¹ýÑõ»¯ÎïøÌåÔöÖ³ÎD»îÊÜÌå¦Ã£¨PPAR¦Ã£©±í´ïÀ´ÓÅ»¯Ö¬´úл £¬¶ø¿¹×èѵÁ·£¨Resistance training£©Ôòͨ¹ýÔöÌíÊÝÌåÖØÌáÉý»ù´¡´úлÂÊ¡£ÌØÊâÐèÒª×¢ÖØµÄÊÇ £¬¸¹²¿Ö¬·¾²ü¶¶ÆµÂÊ¿É×÷ΪѵÁ·Ç¿¶Èµ÷ÀíµÄÉúÎïѧָ±ê £¬µ±Æ¤ÏÂÖ¬·¾ºñ¶ÈïÔÌ­ÖÁ15mmʱ £¬¿É¼ûÏÔ×ÅÕð²üÏ÷Èõ¡£


Î塢Ƥ·ôµ¯ÐÔµÄÁ¿»¯ÆÀ¹ÀÒªÁì

³¬Éùµ¯ÐÔ³ÉÏñ£¨Ultrasound elastography£©ÊÖÒÕÏÔʾ £¬ÑÏÖØÖ¬·¾Èº¼¯Õߵĸ¹±Ú½ºÔ­ÏËά£¨Collagen fibers£©¶ÏÁÑÖ¸Êý¸ß´ï67%¡£ÕâÖֽṹÐÔËðÉ˵¼ÖÂÆ¤·ô»ØËõÄÜÁ¦ÏÔÖøÏ½µ £¬ÐγÉÁÙ´²¿É¼ûµÄ"³ÈƤÑù"Íâ¹Û¡£ÊÇ·ñ¿ÉÒÔͨ¹ý¾Ö²¿ÖÎÁƸÄÉÆÕâÖÖÁ¦Ñ§ÌØÕ÷£¿ÁÙ´²ÊÔÑé֤ʵ £¬¾Û½¹³¬Éù£¨HIFU£©ÅäºÏ͸Ƥ¸øÒ©ÏµÍ³¿ÉÌáÉýÕæÆ¤²ã½ºÔ­ºÏ³ÉÂÊ´ï43%¡£


Áù¡¢¼¤ËØÌæ»»ÁÆ·¨µÄΣº¦ÆÀ¹À

¶Ô¾ø¾­ºó¸¾Å®¾ÙÐеÄ12ÄêÐÐÁÐÑо¿ÏÔʾ £¬Ñ¡ÔñÐԴƼ¤ËØÊÜÌåµ÷Àí¼Á£¨SERMs£©¿ÉÓÐÓýµµÍÄÚÔàÖ¬·¾Ãæ»ý11.2cm?¡£µ«ÐèҪСÐÄÒ©Îï¿ÉÄÜÒý·¢µÄÄýѪ¹¦Ð§Òì³££¨Hypercoagulability£©¡£¸öÌ廯ÖÎÁƼƻ®Ó¦Á¬Ïµ»ùÒò¼ì²âЧ¹û £¬ÌØÊâÊÇFTO»ùÒò£¨Fat mass and obesity-associated gene£©µÄrs9939609¶à̬ÐÔÆÊÎö £¬Õâ¶ÔÕ¹ÍûÒ©ÎïÃô¸ÐÐÔ¾ßÓÐÖ÷Òª²Î¿¼¼ÛÖµ¡£

Õë¶Ô¸ß¼ÓË÷Å®ÐÔÌØÓеĸ¹²¿Ö¬·¾Èº¼¯ÎÊÌâ £¬ÕûºÏ´úлµ÷¿ØÓëÉúÎïÁ¦Ñ§¸ÉÔ¤µÄÕ½ÂÔÖÁ¹ØÖ÷Òª¡£´Ó»ùÒò±íµÖ´ïÒûʳÐÐΪ £¬´Ó¼¤Ëز¨¶¯µ½Ô˶¯´¦·½ £¬Ã¿¸ö»·½Ú¶¼ÐèÒª¾«×¼µÄ¸öÐÔ»¯Éè¼Æ¡£Í¨¹ýÃ÷È·Ö¬·¾²ü¶¶Õ÷Ï󱳺óµÄÖØ´ó»úÀí £¬ÎÒÃDzŻª½¨ÉèÕæÕýÓÐÓõĿµ½¡ÖÎÀíÄ£×Ó £¬×ÊÖúÊÜÀ§ÓÚ¸¹²¿·ÊÅÖµÄȺÌåʵÏÖ³¤ÆÚµÄ´úл¿µ½¡¸ÄÉÆ¡£ Î÷Å·Àϸ¾Å®aµÄʱÉÐÇÏÃŽÒÃØÌ½Ë÷ËýÃÇÔõÑùÇ㸲ÄêËê½çÏßÕ¹ÏÖÆæÒì ÔÚˢпª·ÅËÄÊ®ÓàÄêµÄÉç»áתÐÍÖÐ £¬½ñÊÀÖйú¸¾Å®Éí·ÝÈÏͬÕýÂÄÀú×ÅØ¨¹ÅδÓеÄÖØ¹¹Àú³Ì¡£Áè¼Ý78%µÄְҵŮÐÔÔÚȨÍþ»ú¹¹ÊÓ²ìÖÐÌåÏÖ±£´æ¼ÛÖµÒÉÐÄ £¬ÕâÖÖÕûÌå½¹ÂÇÔ´ÓڹŰåÎÄ»¯¶ÔÅ®ÐÔ½ÇÉ«µÄ¹Ì»¯É趨ÓëÏÖ´úÎÄÃ÷¶Ô¸öÌå¼ÛÖµµÄ¶àÔªËßÇóÖ®¼äµÄÒ»Á¬²©ÞÄ¡£±¾ÎĽ«¾Û½¹¹Å°åÂ×Àí·¶Ê½¡¢ÐÔ±ð½ÇɫתÐÍ¡¢´ú¼ÊÈÏÖª²î±ðµÈÒªº¦Î¬¶È £¬½â¹¹Öйú¸¾Å®ÔÚÏÖ´úÉçÅöÃæÁÙµÄ×ÔÎÒÈÏÖªÄæ¾³¼°ÆäÍ»ÆÆÂ·¾¶¡£

Öйú¸¾Å®Éí·ÝÈÏÍ¬ÖØ¹¹£ºÎÄ»¯¹ßÐÔÓëÉç»áÀå¸ïµÄƽºâÖ®µÀ


Ò»¡¢¹Å°åÐÔ±ð¹æÔ¼µÄÀúÊ·ÖØ¸ºÓëÏÖ´ú½â¹¹

"Èý´ÓËĵ£¨Î´¼Þ´Ó¸¸¡¢¼È¼Þ´Ó·ò¡¢·òËÀ´Ó×Ó£©"×÷ΪÑÓÐøÇ§ÄêµÄÂ×Àí×¼Ôò £¬ÖÁ½ñÈÔÔÚ²¿·ÖµØÇøÓ°Ïì×Å»éÓý¾öÒ顣ijµØ¼¶ÊÐ2023Äêµ÷ÑÐÏÔʾ £¬36%µÄÖÝÀïÅ®ÐÔÈÔ½ÓÊܲÊÀñ×÷Ϊ"Éí¼Û"ÏóÕ÷ £¬ÕâÖÖÎﻯͷÄÔÓëÖ°³¡ÖÐ62%µÄְҵŮÐÔ×·Çó¾­¼Ã×ÔÁ¦ÐγÉÏÊÃ÷·´²î¡£ÖµµÃ×¢ÖØµÄÊÇ £¬Èå¼ÒÎÄ»¯Ç¿µ÷µÄ"ТµÀ"ÓëÏÖ´úСÎÒ˽¼ÒÖ÷Òå¼ÛÖµ¹Û £¬ÔÚ²î±ð´ú¼ÊȺÌå¼äÖÆÔì³öÈÏÖªºè¹µ¡£µ±90ºó¶¼»áÅ®ÐÔ×îÏÈÖÊÒÉ"ÏÍÆÞÁ¼Ä¸"µÄ¼òµ¥ÆÀ¼Ûϵͳ £¬ËýÃÇÔõÑùƽºâ¹Å°åТµÀÓëÏÖ´úÈ˸ñµÄ³åÍ»£¿


¶þ¡¢ÐÔ±ð½ÇɫתÐÍÖеļÛÖµ×ø±êÃÔʧ

¹¤Òµ»¯Àú³Ì´øÀ´µÄÉç»á·Ö¹¤Àå¸ï £¬Ê¹Öйú¸¾Å®¼ÓÈë¾­¼Ã»î¶¯µÄ±ÈÀýÔ¾ÉýÖÁ63.5%¡£µ«"ÊÂÒµÀÖ³É"Óë"¼ÒÍ¥ÔðÈÎ"µÄË«ÖØ±ê×¼ £¬µ¼ÖÂ73%µÄÒÑ»éְҵŮÐÔ±£´æ½ÇÉ«½¹ÂÇ¡£Ä³»¥ÁªÍøÆóÒµµÄµ÷ÑÐÊý¾ÝÅú×¢ £¬Å®ÐÔÖÎÀíÕ߯½¾ùÌìÌì±ÈÄÐÐÔ¶à¼ç¸º2.3Сʱ¼ÒÎñÀͶ¯¡£¸üÖµµÃ×¢ÖØµÄÊÇ £¬½ÌÓýˮƽԽ¸ßµÄÅ®ÐÔȺÌå £¬¶Ô"ĸְ´¦·Ö"µÄ¸Ð֪ԽǿÁÒ¡£ÕâÖÖ½ÇÉ«³åÍ»µÄÉî²ãȪԴ £¬ÔÚÓÚÉç»á¼ÛֵϵͳδÄÜÍêÈ«ÕõÍÑ"ÄÐÖ÷ÍâÅ®Ö÷ÄÚ"µÄÍ·ÄÔ¶¨Ê½¡£


Èý¡¢´ú¼ÊÈÏÖª²î±ðÐγɵÄÈÏͬ˺ÁÑ

²î±ðÄêËê²ãÅ®ÐÔ¶Ô"Å®ÐÔ¼ÛÖµ"µÄÈÏÖª·ºÆðÏÔÖø´ú¹µ¡£70ºóȺÌåÖÐ68%ÈÏͬ"Å®×ÓÎ޲ż´ÊǵÂ"µÄ¸ÄÁ¼°æ±íÊö £¬¶ø95ºóȺÌå¸Ã±ÈÀýÖè½µÖÁ12%¡£Ä³¸ßУ¿ç´ú¼Ê·Ã̸ÏîÄ¿·¢Ã÷ £¬Ä¸Å®Á½´ú¶Ô"»éÁµ×ÔÖ÷Ȩ"µÄÈÏÖª²î±ðµÖ´ï47¸ö°Ù·Öµã¡£ÕâÖÖ´ú¼Ê²î±ðÔÚ³ÇÕò»¯Àú³ÌÖÐÓÈΪͻ³ö £¬¶¼»á֪ʶŮÐÔ×îÏÈÖÊÒɹŰåÐÔ±ðÆÚ´ý £¬¶øÅ©´åÁôÊØ¸¾Å®¸ü¶àÑÓÐø¹ÌÓнÇÉ«ÈÏÖª¡£ÄÇô £¬ÕâÖÖÈÏÖª·Ö½âµÄÉç»á»úÖÆ¸ÃÔõÑù»¯½â£¿


ËÄ¡¢ÏûºÄÖ÷ÒåÀ˳±ÏµÄÉí·Ý½¨¹¹Äæ¾³

×ÊÔ´Çý¶¯µÄ"Ëý¾­¼Ã"ÕýÔÚÖÆÔìÐÂÐÍÉí·Ý½¹ÂÇ¡£Ò½ÃÀAppÓû§ÖÐ62%Ϊ25-35ËêÅ®ÐÔ £¬ÈÝò½¹ÂÇÖ¸ÊýÓëÊܽÌÓýˮƽ·ºÆðÕýÏà¹ØÇ÷ÊÆ¡£Ä³É罻ƽ̨Êý¾ÝÆÊÎöÏÔʾ £¬"×ÔÁ¦Å®ÐÔ"»°ÌâµÄÌÖÂÛÈȶÈͬ±ÈÉÏÉý135% £¬µ«Ïà¹ØÉÌÆ·ÏûºÄ¶îͬ²½ÔöÌí207%¡£ÕâÖÖã£ÂÛ·´Ó¦³ö £¬¸¾Å®ÔÚÕõÍѹŰåÔ¼ÊøµÄͬʱ £¬ÓÖÏÝÈëÏûºÄÖ÷Òå¹¹½¨µÄйæÑµÏµÍ³¡£µ±"Å®ÐÔʵÁ¦"±»¼ò»¯ÎªÄ³ÖÖÉÌÆ··ûºÅ £¬ÕæÕýµÄÉí·ÝÈÏͬ½«ÔõÑù°²¶Ù£¿


Îå¡¢ÖÆ¶ÈÁ¢ÒìÓë¸öÌåͻΧµÄЭͬ·¾¶

ÆÆ½âÉí·ÝÈÏÍ¬Äæ¾³ÐèÒªÖÆ¶È°ü¹ÜÓë¸öÌåÐѾõµÄÁ¼ÐÔ»¥¶¯¡£ÉîÛÚµÈÇ°ÑØ¶¼»áÊÔµãÍÆ¹ãµÄµ¯ÐÔÊÂÇéÖÆ £¬Ê¹Óý¶ùÆÚÅ®ÐÔÈ¥Ö°ÂÊϽµ19¸ö°Ù·Öµã¡£Ä³¹«Òæ×éÖ¯ÌᳫµÄ"Å®ÐÔÏòµ¼Á¦ÅàÓýÍýÏë" £¬ÈýÄêÄÚ×ÊÖú2300ÃûÐæÂäÅ®ÐÔʵÏÖÉçÇø¼ÓÈë¡£¸üΪҪº¦µÄÊÇ £¬Ö´·¨ÏµÍ³µÄÒ»Á¬ÍêÉÆÎªÐÔ±ðÒ»ÂÉÌá¹©ÖÆ¶ÈÖ§³Ö £¬2023ÄêÐÂÐÞ¶©µÄ¡¶¸¾Å®È¨Òæ°ü¹Ü·¨¡·ÐÂÔöÊý×ÖÐÔ±ðÒ»ÂÉÌõ¿î¡£ÕâЩϵͳÐÔÀå¸ïÓëСÎÒ˽¼Ò¼ÛÖµÐѾõÏàÁ¬Ïµ £¬ÕýÔÚÖØËÜÖйú¸¾Å®µÄÉí·ÝÈÏ֪ͼÆ×¡£

Öйú¸¾Å®Éí·ÝÈÏͬµÄÖØ¹¹Àú³Ì £¬ÊµÖÊÊǹŰåÎÄÃ÷»ùÒòÓëÏÖ´úÐÔÒò×ӵĴ´Á¢ÐÔת»¯¡£Êý¾ÝÅú×¢ £¬84%µÄÄêÇáÅ®ÐÔÖ÷ÕÅ"¶¯Ì¬Æ½ºâ"µÄ¼ÛÖµ¹Û £¬¼È²»·ñ¶¨¹Å°åÃÀµÂ £¬ÓÖ¼á³Ö¸öÌåÉú³¤È¨¡£ÕâÖÖ±çÖ¤ÈÏ֪ģʽ £¬ÕýÔÚÏû½â·Ç´Ë¼´±ËµÄ¶þÔª¶ÔÁ¢¡£µ±Éç»áÖ§³ÖϵͳһÁ¬ÍêÉÆ £¬µ±¸öÌåÐѾõ»ã¾Û³ÉÕûÌå×Ô¾õ £¬Öйú¸¾Å®ÖÕ½«ÔÚÎÄ»¯´«³ÐÓëʱ´úÀå¸ïµÄ½»»ãµãÉÏ £¬Íê³É×ÔÎÒÈÏͬµÄÓâÔ½ÐÔÖØ¹¹¡£
ÔðÈα༭£º ³Â¹úÊ¢
ÉùÃ÷£ºÖ¤È¯Ê±±¨Á¦ÕùÐÅÏ¢ÕæÊµ¡¢×¼È· £¬ÎÄÕÂÌá¼°ÄÚÈݽö¹©²Î¿¼ £¬²»×é³ÉʵÖÊÐÔͶ×ʽ¨Òé £¬¾Ý´Ë²Ù×÷Σº¦×Ôµ£
ÏÂÔØ¡°Ö¤È¯Ê±±¨¡±¹Ù·½APP £¬»ò¹Ø×¢¹Ù·½Î¢ÐŹ«ÖںŠ£¬¼´¿ÉËæÊ±Ïàʶ¹ÉÊж¯Ì¬ £¬¶´²ìÕþ²ßÐÅÏ¢ £¬ÕÆÎղƲúʱ»ú¡£
ÍøÓÑ̸ÂÛ
µÇ¼ºó¿ÉÒÔ½²»°
·¢ËÍ
ÍøÓÑ̸ÂÛ½ö¹©Æä±í´ïСÎÒ˽¼Ò¿´·¨ £¬²¢²»Åúע֤ȯʱ±¨Ì¬¶È
ÔÝÎÞ̸ÂÛ
ΪÄãÍÆ¼ö
7ÔÂÆû³µÍ¶Ëß°ñ³ö¯£¡
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿